First phase of ADVANTAGE AF clinical trial achieves safety and effectiveness endpoints for treatment of drug-resistant, symptomatic, persistent atrial fibrillation with the FARAPULSE™ Pulsed Field Ablation System Sub-analysis from OPTION clinical trial highlights consistent safety and...
Read More Details
Finally We wish PressBee provided you with enough information of ( Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation )
Also on site :
- Numbrix 9 - June 27
- NYT 'Connections' Hint and Answers Today, Friday, June 27
- Who Was Eliminated on 'RuPaul's Drag Race All Stars' Season 10 Episode 9 This Week?